Seamless Therapeutics

Provider of gene-editing platform for targeted therapeutics

placeDresden, Saxony, Germany calendar_todayFounded 2022 language seamlesstx.com

Registered entities

Social engagement

Social engagement: 4.8K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Wellington Partners Venture Capital, Forbion.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%

Recent activity

11 May 2026
Event
ASGCT2026
2 Apr 2026
Recognition
28 Jan 2026
Partnership
Eli Lilly and Company
Coming soon